Codexis, Inc. (CDXS)

Codexis, Inc. (CDXS) is a healthcare company (biotechnology) based in the United States. The share price is $1.07, up 0.94% on the day, which values the company at $117.27M. Price as of 18 Nov 2026, 12:55 UTC, from Yahoo Finance.

Key facts

Share price
$1.07+0.94% today
Market value
$117.27M
Funk Score
23/100
Against its own history
Well below its usual priceusual price $1.69
200-week average
$2.7761% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Codexis, Inc. in more detail

CDXS trades at -3.1× next year's expected earnings, 1.3× sales. Measured against its own history, the price is 37% below what its usual multiples would imply ($1.69) — well below its usual price. It sits 61% below its 200-week average of $2.77.

Over the last five fiscal years Codexis, Inc. has compounded revenue 0.4% a year. Its Funk Score is 23 out of 100 (financial strength 3.3, profitability 0.0, growth 2.5, value 3.2, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Share count keeps rising.

Codexis, Inc. (CDXS): questions and answers

What is CDXS's PEG ratio?

Codexis, Inc.'s PEG ratio is 13.53 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Codexis, Inc.'s market cap?

Codexis, Inc. is valued at $117.27M at a share price of $1.07.

Is CDXS overvalued or undervalued?

Against its own history, CDXS is well below its usual price: the price is 37% below the $1.69 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is CDXS above its 200-week moving average?

No. CDXS is 61.3% below its 200-week average of $2.77. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Codexis, Inc. growing?

Over the last five fiscal years Codexis, Inc.'s revenue grew 0.4% a year; over ten years revenue grew 5.3% a year.

Does CDXS pay a dividend?

Codexis, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Codexis, Inc. (CDXS) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/CDXS

Underlying data: Yahoo Finance; company filings with the SEC.